This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy, according to a study published December 12 in the Journal of Nuclear Medicine. In a translational study, researchers synthesized the imaging agent, called F-18 AlF-NOTA-BCP137, and then tested it in mice and humans for the first time.
Our dedicated team is working diligently to minimize wait times and ensure patients receive the best possible care," Jefferson Radiology said in a statement shared Wednesday.
The US Radiology Specialists affiliate has remained outside of Horizon Blue Cross Blue Shield of New Jersey's network since April 1 but recently had a breakthrough.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Radiofrequency ablation (RFA) can successfully treat malignant thyroid nodules with minimal adverse events, according to research published December 11 in Endocrine Practice. A team led by Jennifer Kuo, MD, from New York Presbyterian Hospital Columbia University in New York found that ultrasound-guided RFA achieved remission of hyperthyroidism in over four out of five patients with toxic adenomas or toxic multinodular goiters (MNGs).
The technology is so promising that it is being integrated into GE Healthcares MRI scanners so that providers can conduct more thorough evaluations of how these implants hold up over time.
The technology is so promising that it is being integrated into GE Healthcares MRI scanners so that providers can conduct more thorough evaluations of how these implants hold up over time.
A convolutional neural network (CNN) model used with a one-inhalation lung CT scan protocol can effectively diagnose and stage chronic obstructive pulmonary disease (COPD), researchers have reported. The study findings could help reduce patient exposure to radiation and improve accessibility to CT-based severity assessment, wrote a team of researchers that included PhD candidate Amanda Lee of San Diego State University; Albert Hsiao, MD, PhD, of the University of California, San Diego; and lead
Penn Medicine handled roughly 270,000 radiology exams in its EDs last year, representing a 4.5-fold increase over a decade and necessitating workflow changes.
The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.
Tellica Imaging is awaiting a determination of need decision and approval from the state department of public health in Massachusetts for an expansion of its business in that state, The Bedford Citizen reported. Concentrated mostly in the western U.S., Tellica is a subsidiary of nonprofit Intermountain Health Services. Tellica began in Utah's Ogden, West Valley City, and Orem in 2021 and offers flat-rate pricing for imaging services.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Supply chain emissions significantly impact healthcares carbon footprint, requiring collaborative efforts to implement sustainable and circular practices. The post Uniting Healthcare Forces: Transforming Supply Chains, Reducing Emissions appeared first on Open MedScience.
Although prostatic artery embolization (PAE) has emerged as a widely adopted technique for the management of symptomatic benign prostatic hyperplasia following unsuccessful medical treatment, it presents challenges, especially in the presence of complex penile arterial anastomoses (1). These anastomoses expose patients to an increased risk of nontarget embolization due to the migration of embolic agents into the penile artery, potentially causing cutaneous necrosis of the glans (1%2% of PAE case
The DNA Fragmentation Index (DFI) is a newer and potentially more reliable marker for male infertility, with higher values indicating poorer sperm genetic quality. This study assesses the effect of varicocele embolization on DFI in infertile men. Conducted at a single center from January 2016 to September 2021, this retrospective study involved 22 patients with a mean age of 35.2 4.1 years.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content